Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/26 16:47 | 9/15/26 | TARS | Health | BioPrd | Biological Products, (No Diag | Pyott David E I | CA | D | 1 | M.d | 0 | 0.00 | 0 | 0 | 2 | 10 | I | |||||||||||||||
9/17/26 16:22 | 9/15/26 | TARS | Health | BioPrd | Biological Products, (No Diag | Yarno Wendy L | CA | D | 1 | M.d | 0 | 0.00 | 0 | 0 | 2 | 17 | D | |||||||||||||||
9/17/26 16:22 | 9/15/26 | TARS | Health | BioPrd | Biological Products, (No Diag | Link William J Phd | CA | D | 2 | M.d | 980 | 77.14 | 0 | 13 | 16 | 94 | D | |||||||||||||||
9/17/26 16:22 | 9/15/26 | TARS | Health | BioPrd | Biological Products, (No Diag | Link William J Phd | CA | D | 2 | S.d | -980 | 77.14 | 0 | -13 | 94 | D | ||||||||||||||||
9/9/26 16:14 | 9/4/26 | TARS | Health | BioPrd | Biological Products, (No Diag | Azamian Bobak R. | CA | DO | P,CEO,Bo | 3 | S | -2,322 | 77.39 | 0 | -30 | 881 | I | |||||||||||||||
9/9/26 16:13 | 9/4/26 | TARS | Health | BioPrd | Biological Products, (No Diag | Lin Elizabeth Yeu | CA | O | Chief Me | 1 | S | -1,221 | 87.50 | 0 | -14 | 16 | M | |||||||||||||||
9/9/26 16:12 | 9/4/26 | TARS | Health | BioPrd | Biological Products, (No Diag | Neervannan Seshadri | CA | O | COO | 1 | S | -388 | 85.00 | 0 | -5 | 79 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |